Gene · 6571
Papers3,040
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,040
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Associations between methamphetamine use disorder and SLC18A1, SLC18A2, BDNF, and FAAH gene sequence variants and expression levels. | Dialogues Clin Neurosci | 2024 | 39394974 | PubTator, text mining | PubMed |
| Role of vesicular monoamine transporter-2 for treating attention deficit hyperactivity disorder: a review. | Psychopharmacology (Berl) | 2024 | 39302436 | PubTator, text mining | PubMed |
| Neurotransmitter recognition by human vesicular monoamine transporter 2. | Nat Commun | 2024 | 39284862 | PubTator, text mining | PubMed |
| Atypical Antipsychotic-Induced Tardive Dyskinesia in a Middle-Aged Schizophrenic Patient: A Case Report. | Cureus | 2024 | 39205717 | PubTator, text mining | PubMed |
| Dopaminergic Neurons in Zona Incerta Drives Appetitive Self-Grooming. | Adv Sci (Weinh) | 2024 | 39099402 | PubTator, text mining | PubMed |
| Engineering of a mammalian VMAT2 for cryo-EM analysis results in non-canonical protein folding. | Nat Commun | 2024 | 39095428 | PubTator, text mining | PubMed |
| Tricyclic and tetracyclic antidepressants upregulate VMAT2 activity and rescue disease-causing VMAT2 variants. | Neuropsychopharmacology | 2024 | 39060436 | PubTator, text mining | PubMed |
| Profiling deutetrabenazine extended-release tablets for tardive dyskinesia and chorea associated with Huntington's disease. | Expert Rev Neurother | 2024 | 38982802 | PubTator, text mining | PubMed |
| Endocrine toxicity of atrazine and its underlying mechanisms. | Toxicology | 2024 | 38815618 | PubTator, text mining | PubMed |
| Structural snapshots of human VMAT2 reveal insights into substrate recognition and proton coupling mechanism. | Cell Res | 2024 | 38777861 | PubTator, text mining | PubMed |
| Novel SLC18A2 Variant in Infantile Dystonia-Parkinsonism Type 2. | Case Rep Neurol Med | 2024 | 38716424 | PubTator, text mining | PubMed |
| Theobromine improves hyperactivity, inattention, and working memory via modulation of dopaminergic neural function in the frontal cortex of spontaneously hypertensive rats. | Food Funct | 2024 | 38713055 | PubTator, text mining | PubMed |
| Multi-tracer PET correlation analysis reveals disease-specific patterns in Parkinson's disease and asymptomatic LRRK2 pathogenic variant carriers compared to healthy controls. | Neuroimage Clin | 2024 | 38599001 | PubTator, text mining | PubMed |
| Structural mechanisms for VMAT2 inhibition by tetrabenazine. | Elife | 2024 | 38517752 | Swiss-Prot, curated | PubMed |
| N-acetylcysteine increases dopamine release and prevents the deleterious effects of 6-OHDA on the expression of VMAT2, α-synuclein, and tyrosine hydroxylase. | Neurol Res | 2024 | 38498979 | PubTator, text mining | PubMed |
| Comparative Analysis of Deutetrabenazine and Valbenazine as VMAT2 Inhibitors for Tardive Dyskinesia: A Systematic Review. | Tremor Other Hyperkinet Mov (N Y) | 2024 | 38497033 | PubTator, text mining | PubMed |
| Striatal and Extrastriatal Monoaminergic Disruption in Progressive Supranuclear Palsy. | Mov Disord | 2024 | 38477228 | PubTator, text mining | PubMed |
| VMAT structures reveal exciting targets for drug development. | Trends Pharmacol Sci | 2024 | 38429134 | PubTator, text mining | PubMed |
| Protection against β-N-methylamino-l-alanineꟷinduced vesicular monoamine transporter 2 inhibition by hydroxyl-containing proteinogenic amino acids. | Environ Toxicol Pharmacol | 2024 | 38403141 | PubTator, text mining | PubMed |
| Parkinsonism-dystonia-2: Case-series study from Saudi Arabia. | Ann Clin Transl Neurol | 2024 | 38389300 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6571/papers?page=8